Global Nuclide Market Growth (Status and Outlook) 2026-2032
The global Nuclide market size is predicted to grow from US$ 4381 million in 2025 to US$ 7040 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032.
A nuclide is an atomic nucleus defined by a specific number of protons and neutrons; radioactive nuclides emit ?, ?, or ? radiation during decay and are widely applied in medical diagnostics, therapy, industrial testing, and research. Medical nuclides play a central role in nuclear medicine imaging and radiotherapeutics: as radiotracers they enable molecular imaging (e.g., PET, SPECT) for early detection, staging, and treatment monitoring; as radiopharmaceuticals they serve in targeted and palliative therapies. The nuclide value chain spans isotope production (research reactors or cyclotrons), radiopharmaceutical manufacturing, specialized logistics, and radioactive waste handling — an ecosystem characterized by high technical barriers, strict regulation, and supply chains sensitive to national security and policy. With the rise of precision medicine and targeted radiotherapy, medical nuclides are evolving from single-use imaging agents toward integrated diagnostic-therapeutic, patient-tailored solutions, positioning themselves as strategic materials at the intersection of healthcare and life sciences.
Nuclides, as core inputs for molecular imaging and radiotherapeutics, are seeing their clinical and commercial value amplified by precision medicine, radiopharmaceutical innovation, and cross-disciplinary R&D. Healthcare systems’ emphasis on early diagnosis and personalized therapy drives demand for radiotracers and therapeutic nuclides. Leading companies’ annual reports note strategic collaborations with pharmaceutical firms, imaging-equipment vendors, and hospitals — collaborations that accelerate technology translation and market penetration. Governmental and international initiatives that support critical isotope supply, build infrastructure, and fund supply-chain resilience further lower barriers and create scale opportunities.
The nuclide sector is inherently subject to stringent regulation and complex compliance regimes: production, transport, and clinical use of radioactive materials are tightly controlled, raising entry and expansion costs. Upstream isotope capacity is concentrated in a limited number of reactors and accelerators; outages or policy shifts can quickly tighten supply — a vulnerability noted in corporate filings and public disclosures. Moreover, commercialization of radiopharmaceuticals requires alignment with regulatory approvals, reimbursement mechanisms, and hospital care pathways, making market rollout sensitive to multiple policy and stakeholder actions.
Clinical demand is shifting from “imaging adjuncts” to integrated diagnostic-therapeutic workflows: molecular imaging is used for patient stratification and to guide personalized radiopharmaceutical dosing, while therapeutic nuclides are gaining traction in targeted therapies. Large tertiary hospitals remain early adopters, but regional and specialty centers are expanding access, broadening use cases and service networks. Annual reports and industry analyses indicate business models are evolving from pure supply to solution provision—co-developing clinical trials and services with hospitals and pharma partners—thereby enhancing customer stickiness and pricing power.
Key upstream elements include isotope production capacity (reactors and cyclotrons), radiochemical precursors and labeling reagents, and radiation-tolerant high-performance materials and precision electronics. Scintillators, target materials, and radiation-hard components directly affect imaging quality and production throughput, while radiopharmaceutical synthesis depends on GMP facilities and cold-chain logistics. Government and corporate disclosures emphasize that localizing production capacity, diversifying supply sources, and investing in infrastructure are essential to improve supply stability and enable sustainable industry growth.
This Insight Report provides a comprehensive analysis of the global Nuclide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nuclide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclide.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclide market by product type, application, key players and key regions and countries.
A nuclide is an atomic nucleus defined by a specific number of protons and neutrons; radioactive nuclides emit ?, ?, or ? radiation during decay and are widely applied in medical diagnostics, therapy, industrial testing, and research. Medical nuclides play a central role in nuclear medicine imaging and radiotherapeutics: as radiotracers they enable molecular imaging (e.g., PET, SPECT) for early detection, staging, and treatment monitoring; as radiopharmaceuticals they serve in targeted and palliative therapies. The nuclide value chain spans isotope production (research reactors or cyclotrons), radiopharmaceutical manufacturing, specialized logistics, and radioactive waste handling — an ecosystem characterized by high technical barriers, strict regulation, and supply chains sensitive to national security and policy. With the rise of precision medicine and targeted radiotherapy, medical nuclides are evolving from single-use imaging agents toward integrated diagnostic-therapeutic, patient-tailored solutions, positioning themselves as strategic materials at the intersection of healthcare and life sciences.
Nuclides, as core inputs for molecular imaging and radiotherapeutics, are seeing their clinical and commercial value amplified by precision medicine, radiopharmaceutical innovation, and cross-disciplinary R&D. Healthcare systems’ emphasis on early diagnosis and personalized therapy drives demand for radiotracers and therapeutic nuclides. Leading companies’ annual reports note strategic collaborations with pharmaceutical firms, imaging-equipment vendors, and hospitals — collaborations that accelerate technology translation and market penetration. Governmental and international initiatives that support critical isotope supply, build infrastructure, and fund supply-chain resilience further lower barriers and create scale opportunities.
The nuclide sector is inherently subject to stringent regulation and complex compliance regimes: production, transport, and clinical use of radioactive materials are tightly controlled, raising entry and expansion costs. Upstream isotope capacity is concentrated in a limited number of reactors and accelerators; outages or policy shifts can quickly tighten supply — a vulnerability noted in corporate filings and public disclosures. Moreover, commercialization of radiopharmaceuticals requires alignment with regulatory approvals, reimbursement mechanisms, and hospital care pathways, making market rollout sensitive to multiple policy and stakeholder actions.
Clinical demand is shifting from “imaging adjuncts” to integrated diagnostic-therapeutic workflows: molecular imaging is used for patient stratification and to guide personalized radiopharmaceutical dosing, while therapeutic nuclides are gaining traction in targeted therapies. Large tertiary hospitals remain early adopters, but regional and specialty centers are expanding access, broadening use cases and service networks. Annual reports and industry analyses indicate business models are evolving from pure supply to solution provision—co-developing clinical trials and services with hospitals and pharma partners—thereby enhancing customer stickiness and pricing power.
Key upstream elements include isotope production capacity (reactors and cyclotrons), radiochemical precursors and labeling reagents, and radiation-tolerant high-performance materials and precision electronics. Scintillators, target materials, and radiation-hard components directly affect imaging quality and production throughput, while radiopharmaceutical synthesis depends on GMP facilities and cold-chain logistics. Government and corporate disclosures emphasize that localizing production capacity, diversifying supply sources, and investing in infrastructure are essential to improve supply stability and enable sustainable industry growth.
Report Scope
LPI (LP Information)' newest research report, the “Nuclide Industry Forecast” looks at past sales and reviews total world Nuclide sales in 2025, providing a comprehensive analysis by region and market sector of projected Nuclide sales for 2026 through 2032. With Nuclide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclide industry.This Insight Report provides a comprehensive analysis of the global Nuclide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nuclide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclide.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclide market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Type:
- Tc-99m
- F-18
- I-131
- Co-60
- Other
Segmentation by Application:
- Industry
- Medical
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Curium
- MDS Nordion
- IRE (Institute for Radioelements)
- NTP Radioisotopes
- JSC Isotope
- ANM (ANSTO Nuclear Medicine)
- Nusano
- International Isotopes
- NorthStar Medical Radioisotopes
- China Isotope & Radiation
- NRG
- Polatom
- ASP Isotopes
- Rosatom
- Eckert & Ziegler
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclide Market Size (2021-2032)
2.1.2 Nuclide Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Nuclide by Country/Region (2021, 2025 & 2032)
2.2 Nuclide Segment by Type
2.2.1 Tc-99m
2.2.2 F-18
2.2.3 I-131
2.2.4 Co-60
2.2.5 Other
2.2.6 Nuclide Market Size by Type
2.2.6.1 Nuclide Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Nuclide Market Size Market Share by Type (2021-2026)
2.3 Nuclide Segment by Application
2.3.1 Industry
2.3.2 Medical
2.3.3 Other
2.3.4 Nuclide Market Size by Application
2.3.4.1 Nuclide Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Nuclide Market Size Market Share by Application (2021-2026)
3 NUCLIDE MARKET SIZE BY PLAYER
3.1 Nuclide Market Size Market Share by Player
3.1.1 Global Nuclide Revenue by Player (2021-2026)
3.1.2 Global Nuclide Revenue Market Share by Player (2021-2026)
3.2 Global Nuclide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLIDE BY REGION
4.1 Nuclide Market Size by Region (2021-2026)
4.2 Global Nuclide Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nuclide Market Size Growth (2021-2026)
4.4 APAC Nuclide Market Size Growth (2021-2026)
4.5 Europe Nuclide Market Size Growth (2021-2026)
4.6 Middle East & Africa Nuclide Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Nuclide Market Size by Country (2021-2026)
5.2 Americas Nuclide Market Size by Type (2021-2026)
5.3 Americas Nuclide Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclide Market Size by Region (2021-2026)
6.2 APAC Nuclide Market Size by Type (2021-2026)
6.3 APAC Nuclide Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nuclide Market Size by Country (2021-2026)
7.2 Europe Nuclide Market Size by Type (2021-2026)
7.3 Europe Nuclide Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclide by Region (2021-2026)
8.2 Middle East & Africa Nuclide Market Size by Type (2021-2026)
8.3 Middle East & Africa Nuclide Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLIDE MARKET FORECAST
10.1 Global Nuclide Forecast by Region (2027-2032)
10.1.1 Global Nuclide Forecast by Region (2027-2032)
10.1.2 Americas Nuclide Forecast
10.1.3 APAC Nuclide Forecast
10.1.4 Europe Nuclide Forecast
10.1.5 Middle East & Africa Nuclide Forecast
10.2 Americas Nuclide Forecast by Country (2027-2032)
10.2.1 United States Market Nuclide Forecast
10.2.2 Canada Market Nuclide Forecast
10.2.3 Mexico Market Nuclide Forecast
10.2.4 Brazil Market Nuclide Forecast
10.3 APAC Nuclide Forecast by Region (2027-2032)
10.3.1 China Nuclide Market Forecast
10.3.2 Japan Market Nuclide Forecast
10.3.3 Korea Market Nuclide Forecast
10.3.4 Southeast Asia Market Nuclide Forecast
10.3.5 India Market Nuclide Forecast
10.3.6 Australia Market Nuclide Forecast
10.4 Europe Nuclide Forecast by Country (2027-2032)
10.4.1 Germany Market Nuclide Forecast
10.4.2 France Market Nuclide Forecast
10.4.3 UK Market Nuclide Forecast
10.4.4 Italy Market Nuclide Forecast
10.4.5 Russia Market Nuclide Forecast
10.5 Middle East & Africa Nuclide Forecast by Region (2027-2032)
10.5.1 Egypt Market Nuclide Forecast
10.5.2 South Africa Market Nuclide Forecast
10.5.3 Israel Market Nuclide Forecast
10.5.4 Turkey Market Nuclide Forecast
10.6 Global Nuclide Forecast by Type (2027-2032)
10.7 Global Nuclide Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Nuclide Forecast
11 KEY PLAYERS ANALYSIS
11.1 Curium
11.1.1 Curium Company Information
11.1.2 Curium Nuclide Product Offered
11.1.3 Curium Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Curium Main Business Overview
11.1.5 Curium Latest Developments
11.2 MDS Nordion
11.2.1 MDS Nordion Company Information
11.2.2 MDS Nordion Nuclide Product Offered
11.2.3 MDS Nordion Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 MDS Nordion Main Business Overview
11.2.5 MDS Nordion Latest Developments
11.3 IRE (Institute for Radioelements)
11.3.1 IRE (Institute for Radioelements) Company Information
11.3.2 IRE (Institute for Radioelements) Nuclide Product Offered
11.3.3 IRE (Institute for Radioelements) Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 IRE (Institute for Radioelements) Main Business Overview
11.3.5 IRE (Institute for Radioelements) Latest Developments
11.4 NTP Radioisotopes
11.4.1 NTP Radioisotopes Company Information
11.4.2 NTP Radioisotopes Nuclide Product Offered
11.4.3 NTP Radioisotopes Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 NTP Radioisotopes Main Business Overview
11.4.5 NTP Radioisotopes Latest Developments
11.5 JSC Isotope
11.5.1 JSC Isotope Company Information
11.5.2 JSC Isotope Nuclide Product Offered
11.5.3 JSC Isotope Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 JSC Isotope Main Business Overview
11.5.5 JSC Isotope Latest Developments
11.6 ANM (ANSTO Nuclear Medicine)
11.6.1 ANM (ANSTO Nuclear Medicine) Company Information
11.6.2 ANM (ANSTO Nuclear Medicine) Nuclide Product Offered
11.6.3 ANM (ANSTO Nuclear Medicine) Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 ANM (ANSTO Nuclear Medicine) Main Business Overview
11.6.5 ANM (ANSTO Nuclear Medicine) Latest Developments
11.7 Nusano
11.7.1 Nusano Company Information
11.7.2 Nusano Nuclide Product Offered
11.7.3 Nusano Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Nusano Main Business Overview
11.7.5 Nusano Latest Developments
11.8 International Isotopes
11.8.1 International Isotopes Company Information
11.8.2 International Isotopes Nuclide Product Offered
11.8.3 International Isotopes Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 International Isotopes Main Business Overview
11.8.5 International Isotopes Latest Developments
11.9 NorthStar Medical Radioisotopes
11.9.1 NorthStar Medical Radioisotopes Company Information
11.9.2 NorthStar Medical Radioisotopes Nuclide Product Offered
11.9.3 NorthStar Medical Radioisotopes Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 NorthStar Medical Radioisotopes Main Business Overview
11.9.5 NorthStar Medical Radioisotopes Latest Developments
11.10 China Isotope & Radiation
11.10.1 China Isotope & Radiation Company Information
11.10.2 China Isotope & Radiation Nuclide Product Offered
11.10.3 China Isotope & Radiation Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 China Isotope & Radiation Main Business Overview
11.10.5 China Isotope & Radiation Latest Developments
11.11 NRG
11.11.1 NRG Company Information
11.11.2 NRG Nuclide Product Offered
11.11.3 NRG Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 NRG Main Business Overview
11.11.5 NRG Latest Developments
11.12 Polatom
11.12.1 Polatom Company Information
11.12.2 Polatom Nuclide Product Offered
11.12.3 Polatom Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Polatom Main Business Overview
11.12.5 Polatom Latest Developments
11.13 ASP Isotopes
11.13.1 ASP Isotopes Company Information
11.13.2 ASP Isotopes Nuclide Product Offered
11.13.3 ASP Isotopes Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 ASP Isotopes Main Business Overview
11.13.5 ASP Isotopes Latest Developments
11.14 Rosatom
11.14.1 Rosatom Company Information
11.14.2 Rosatom Nuclide Product Offered
11.14.3 Rosatom Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Rosatom Main Business Overview
11.14.5 Rosatom Latest Developments
11.15 Eckert & Ziegler
11.15.1 Eckert & Ziegler Company Information
11.15.2 Eckert & Ziegler Nuclide Product Offered
11.15.3 Eckert & Ziegler Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Eckert & Ziegler Main Business Overview
11.15.5 Eckert & Ziegler Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclide Market Size (2021-2032)
2.1.2 Nuclide Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Nuclide by Country/Region (2021, 2025 & 2032)
2.2 Nuclide Segment by Type
2.2.1 Tc-99m
2.2.2 F-18
2.2.3 I-131
2.2.4 Co-60
2.2.5 Other
2.2.6 Nuclide Market Size by Type
2.2.6.1 Nuclide Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Nuclide Market Size Market Share by Type (2021-2026)
2.3 Nuclide Segment by Application
2.3.1 Industry
2.3.2 Medical
2.3.3 Other
2.3.4 Nuclide Market Size by Application
2.3.4.1 Nuclide Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Nuclide Market Size Market Share by Application (2021-2026)
3 NUCLIDE MARKET SIZE BY PLAYER
3.1 Nuclide Market Size Market Share by Player
3.1.1 Global Nuclide Revenue by Player (2021-2026)
3.1.2 Global Nuclide Revenue Market Share by Player (2021-2026)
3.2 Global Nuclide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLIDE BY REGION
4.1 Nuclide Market Size by Region (2021-2026)
4.2 Global Nuclide Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nuclide Market Size Growth (2021-2026)
4.4 APAC Nuclide Market Size Growth (2021-2026)
4.5 Europe Nuclide Market Size Growth (2021-2026)
4.6 Middle East & Africa Nuclide Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Nuclide Market Size by Country (2021-2026)
5.2 Americas Nuclide Market Size by Type (2021-2026)
5.3 Americas Nuclide Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclide Market Size by Region (2021-2026)
6.2 APAC Nuclide Market Size by Type (2021-2026)
6.3 APAC Nuclide Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nuclide Market Size by Country (2021-2026)
7.2 Europe Nuclide Market Size by Type (2021-2026)
7.3 Europe Nuclide Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclide by Region (2021-2026)
8.2 Middle East & Africa Nuclide Market Size by Type (2021-2026)
8.3 Middle East & Africa Nuclide Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLIDE MARKET FORECAST
10.1 Global Nuclide Forecast by Region (2027-2032)
10.1.1 Global Nuclide Forecast by Region (2027-2032)
10.1.2 Americas Nuclide Forecast
10.1.3 APAC Nuclide Forecast
10.1.4 Europe Nuclide Forecast
10.1.5 Middle East & Africa Nuclide Forecast
10.2 Americas Nuclide Forecast by Country (2027-2032)
10.2.1 United States Market Nuclide Forecast
10.2.2 Canada Market Nuclide Forecast
10.2.3 Mexico Market Nuclide Forecast
10.2.4 Brazil Market Nuclide Forecast
10.3 APAC Nuclide Forecast by Region (2027-2032)
10.3.1 China Nuclide Market Forecast
10.3.2 Japan Market Nuclide Forecast
10.3.3 Korea Market Nuclide Forecast
10.3.4 Southeast Asia Market Nuclide Forecast
10.3.5 India Market Nuclide Forecast
10.3.6 Australia Market Nuclide Forecast
10.4 Europe Nuclide Forecast by Country (2027-2032)
10.4.1 Germany Market Nuclide Forecast
10.4.2 France Market Nuclide Forecast
10.4.3 UK Market Nuclide Forecast
10.4.4 Italy Market Nuclide Forecast
10.4.5 Russia Market Nuclide Forecast
10.5 Middle East & Africa Nuclide Forecast by Region (2027-2032)
10.5.1 Egypt Market Nuclide Forecast
10.5.2 South Africa Market Nuclide Forecast
10.5.3 Israel Market Nuclide Forecast
10.5.4 Turkey Market Nuclide Forecast
10.6 Global Nuclide Forecast by Type (2027-2032)
10.7 Global Nuclide Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Nuclide Forecast
11 KEY PLAYERS ANALYSIS
11.1 Curium
11.1.1 Curium Company Information
11.1.2 Curium Nuclide Product Offered
11.1.3 Curium Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Curium Main Business Overview
11.1.5 Curium Latest Developments
11.2 MDS Nordion
11.2.1 MDS Nordion Company Information
11.2.2 MDS Nordion Nuclide Product Offered
11.2.3 MDS Nordion Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 MDS Nordion Main Business Overview
11.2.5 MDS Nordion Latest Developments
11.3 IRE (Institute for Radioelements)
11.3.1 IRE (Institute for Radioelements) Company Information
11.3.2 IRE (Institute for Radioelements) Nuclide Product Offered
11.3.3 IRE (Institute for Radioelements) Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 IRE (Institute for Radioelements) Main Business Overview
11.3.5 IRE (Institute for Radioelements) Latest Developments
11.4 NTP Radioisotopes
11.4.1 NTP Radioisotopes Company Information
11.4.2 NTP Radioisotopes Nuclide Product Offered
11.4.3 NTP Radioisotopes Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 NTP Radioisotopes Main Business Overview
11.4.5 NTP Radioisotopes Latest Developments
11.5 JSC Isotope
11.5.1 JSC Isotope Company Information
11.5.2 JSC Isotope Nuclide Product Offered
11.5.3 JSC Isotope Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 JSC Isotope Main Business Overview
11.5.5 JSC Isotope Latest Developments
11.6 ANM (ANSTO Nuclear Medicine)
11.6.1 ANM (ANSTO Nuclear Medicine) Company Information
11.6.2 ANM (ANSTO Nuclear Medicine) Nuclide Product Offered
11.6.3 ANM (ANSTO Nuclear Medicine) Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 ANM (ANSTO Nuclear Medicine) Main Business Overview
11.6.5 ANM (ANSTO Nuclear Medicine) Latest Developments
11.7 Nusano
11.7.1 Nusano Company Information
11.7.2 Nusano Nuclide Product Offered
11.7.3 Nusano Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Nusano Main Business Overview
11.7.5 Nusano Latest Developments
11.8 International Isotopes
11.8.1 International Isotopes Company Information
11.8.2 International Isotopes Nuclide Product Offered
11.8.3 International Isotopes Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 International Isotopes Main Business Overview
11.8.5 International Isotopes Latest Developments
11.9 NorthStar Medical Radioisotopes
11.9.1 NorthStar Medical Radioisotopes Company Information
11.9.2 NorthStar Medical Radioisotopes Nuclide Product Offered
11.9.3 NorthStar Medical Radioisotopes Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 NorthStar Medical Radioisotopes Main Business Overview
11.9.5 NorthStar Medical Radioisotopes Latest Developments
11.10 China Isotope & Radiation
11.10.1 China Isotope & Radiation Company Information
11.10.2 China Isotope & Radiation Nuclide Product Offered
11.10.3 China Isotope & Radiation Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 China Isotope & Radiation Main Business Overview
11.10.5 China Isotope & Radiation Latest Developments
11.11 NRG
11.11.1 NRG Company Information
11.11.2 NRG Nuclide Product Offered
11.11.3 NRG Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 NRG Main Business Overview
11.11.5 NRG Latest Developments
11.12 Polatom
11.12.1 Polatom Company Information
11.12.2 Polatom Nuclide Product Offered
11.12.3 Polatom Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Polatom Main Business Overview
11.12.5 Polatom Latest Developments
11.13 ASP Isotopes
11.13.1 ASP Isotopes Company Information
11.13.2 ASP Isotopes Nuclide Product Offered
11.13.3 ASP Isotopes Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 ASP Isotopes Main Business Overview
11.13.5 ASP Isotopes Latest Developments
11.14 Rosatom
11.14.1 Rosatom Company Information
11.14.2 Rosatom Nuclide Product Offered
11.14.3 Rosatom Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Rosatom Main Business Overview
11.14.5 Rosatom Latest Developments
11.15 Eckert & Ziegler
11.15.1 Eckert & Ziegler Company Information
11.15.2 Eckert & Ziegler Nuclide Product Offered
11.15.3 Eckert & Ziegler Nuclide Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Eckert & Ziegler Main Business Overview
11.15.5 Eckert & Ziegler Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nuclide Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Nuclide Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Tc-99m
Table 4. Major Players of F-18
Table 5. Major Players of I-131
Table 6. Major Players of Co-60
Table 7. Major Players of Other
Table 8. Nuclide Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Nuclide Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Nuclide Market Size Market Share by Type (2021-2026)
Table 11. Nuclide Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Nuclide Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Nuclide Market Size Market Share by Application (2021-2026)
Table 14. Global Nuclide Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Nuclide Revenue Market Share by Player (2021-2026)
Table 16. Nuclide Key Players Head office and Products Offered
Table 17. Nuclide Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Nuclide Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Nuclide Market Size Market Share by Region (2021-2026)
Table 22. Global Nuclide Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Nuclide Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Nuclide Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Nuclide Market Size Market Share by Country (2021-2026)
Table 26. Americas Nuclide Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Nuclide Market Size Market Share by Type (2021-2026)
Table 28. Americas Nuclide Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Nuclide Market Size Market Share by Application (2021-2026)
Table 30. APAC Nuclide Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Nuclide Market Size Market Share by Region (2021-2026)
Table 32. APAC Nuclide Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Nuclide Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Nuclide Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Nuclide Market Size Market Share by Country (2021-2026)
Table 36. Europe Nuclide Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Nuclide Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Nuclide Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Nuclide Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Nuclide Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Nuclide
Table 42. Key Market Challenges & Risks of Nuclide
Table 43. Key Industry Trends of Nuclide
Table 44. Global Nuclide Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Nuclide Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Nuclide Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Nuclide Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Curium Details, Company Type, Nuclide Area Served and Its Competitors
Table 49. Curium Nuclide Product Offered
Table 50. Curium Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Curium Main Business
Table 52. Curium Latest Developments
Table 53. MDS Nordion Details, Company Type, Nuclide Area Served and Its Competitors
Table 54. MDS Nordion Nuclide Product Offered
Table 55. MDS Nordion Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. MDS Nordion Main Business
Table 57. MDS Nordion Latest Developments
Table 58. IRE (Institute for Radioelements) Details, Company Type, Nuclide Area Served and Its Competitors
Table 59. IRE (Institute for Radioelements) Nuclide Product Offered
Table 60. IRE (Institute for Radioelements) Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. IRE (Institute for Radioelements) Main Business
Table 62. IRE (Institute for Radioelements) Latest Developments
Table 63. NTP Radioisotopes Details, Company Type, Nuclide Area Served and Its Competitors
Table 64. NTP Radioisotopes Nuclide Product Offered
Table 65. NTP Radioisotopes Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. NTP Radioisotopes Main Business
Table 67. NTP Radioisotopes Latest Developments
Table 68. JSC Isotope Details, Company Type, Nuclide Area Served and Its Competitors
Table 69. JSC Isotope Nuclide Product Offered
Table 70. JSC Isotope Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. JSC Isotope Main Business
Table 72. JSC Isotope Latest Developments
Table 73. ANM (ANSTO Nuclear Medicine) Details, Company Type, Nuclide Area Served and Its Competitors
Table 74. ANM (ANSTO Nuclear Medicine) Nuclide Product Offered
Table 75. ANM (ANSTO Nuclear Medicine) Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. ANM (ANSTO Nuclear Medicine) Main Business
Table 77. ANM (ANSTO Nuclear Medicine) Latest Developments
Table 78. Nusano Details, Company Type, Nuclide Area Served and Its Competitors
Table 79. Nusano Nuclide Product Offered
Table 80. Nusano Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Nusano Main Business
Table 82. Nusano Latest Developments
Table 83. International Isotopes Details, Company Type, Nuclide Area Served and Its Competitors
Table 84. International Isotopes Nuclide Product Offered
Table 85. International Isotopes Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. International Isotopes Main Business
Table 87. International Isotopes Latest Developments
Table 88. NorthStar Medical Radioisotopes Details, Company Type, Nuclide Area Served and Its Competitors
Table 89. NorthStar Medical Radioisotopes Nuclide Product Offered
Table 90. NorthStar Medical Radioisotopes Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. NorthStar Medical Radioisotopes Main Business
Table 92. NorthStar Medical Radioisotopes Latest Developments
Table 93. China Isotope & Radiation Details, Company Type, Nuclide Area Served and Its Competitors
Table 94. China Isotope & Radiation Nuclide Product Offered
Table 95. China Isotope & Radiation Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. China Isotope & Radiation Main Business
Table 97. China Isotope & Radiation Latest Developments
Table 98. NRG Details, Company Type, Nuclide Area Served and Its Competitors
Table 99. NRG Nuclide Product Offered
Table 100. NRG Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. NRG Main Business
Table 102. NRG Latest Developments
Table 103. Polatom Details, Company Type, Nuclide Area Served and Its Competitors
Table 104. Polatom Nuclide Product Offered
Table 105. Polatom Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Polatom Main Business
Table 107. Polatom Latest Developments
Table 108. ASP Isotopes Details, Company Type, Nuclide Area Served and Its Competitors
Table 109. ASP Isotopes Nuclide Product Offered
Table 110. ASP Isotopes Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. ASP Isotopes Main Business
Table 112. ASP Isotopes Latest Developments
Table 113. Rosatom Details, Company Type, Nuclide Area Served and Its Competitors
Table 114. Rosatom Nuclide Product Offered
Table 115. Rosatom Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Rosatom Main Business
Table 117. Rosatom Latest Developments
Table 118. Eckert & Ziegler Details, Company Type, Nuclide Area Served and Its Competitors
Table 119. Eckert & Ziegler Nuclide Product Offered
Table 120. Eckert & Ziegler Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Eckert & Ziegler Main Business
Table 122. Eckert & Ziegler Latest Developments
Table 1. Nuclide Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Nuclide Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Tc-99m
Table 4. Major Players of F-18
Table 5. Major Players of I-131
Table 6. Major Players of Co-60
Table 7. Major Players of Other
Table 8. Nuclide Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Nuclide Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Nuclide Market Size Market Share by Type (2021-2026)
Table 11. Nuclide Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Nuclide Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Nuclide Market Size Market Share by Application (2021-2026)
Table 14. Global Nuclide Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Nuclide Revenue Market Share by Player (2021-2026)
Table 16. Nuclide Key Players Head office and Products Offered
Table 17. Nuclide Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Nuclide Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Nuclide Market Size Market Share by Region (2021-2026)
Table 22. Global Nuclide Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Nuclide Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Nuclide Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Nuclide Market Size Market Share by Country (2021-2026)
Table 26. Americas Nuclide Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Nuclide Market Size Market Share by Type (2021-2026)
Table 28. Americas Nuclide Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Nuclide Market Size Market Share by Application (2021-2026)
Table 30. APAC Nuclide Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Nuclide Market Size Market Share by Region (2021-2026)
Table 32. APAC Nuclide Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Nuclide Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Nuclide Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Nuclide Market Size Market Share by Country (2021-2026)
Table 36. Europe Nuclide Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Nuclide Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Nuclide Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Nuclide Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Nuclide Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Nuclide
Table 42. Key Market Challenges & Risks of Nuclide
Table 43. Key Industry Trends of Nuclide
Table 44. Global Nuclide Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Nuclide Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Nuclide Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Nuclide Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Curium Details, Company Type, Nuclide Area Served and Its Competitors
Table 49. Curium Nuclide Product Offered
Table 50. Curium Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Curium Main Business
Table 52. Curium Latest Developments
Table 53. MDS Nordion Details, Company Type, Nuclide Area Served and Its Competitors
Table 54. MDS Nordion Nuclide Product Offered
Table 55. MDS Nordion Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. MDS Nordion Main Business
Table 57. MDS Nordion Latest Developments
Table 58. IRE (Institute for Radioelements) Details, Company Type, Nuclide Area Served and Its Competitors
Table 59. IRE (Institute for Radioelements) Nuclide Product Offered
Table 60. IRE (Institute for Radioelements) Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. IRE (Institute for Radioelements) Main Business
Table 62. IRE (Institute for Radioelements) Latest Developments
Table 63. NTP Radioisotopes Details, Company Type, Nuclide Area Served and Its Competitors
Table 64. NTP Radioisotopes Nuclide Product Offered
Table 65. NTP Radioisotopes Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. NTP Radioisotopes Main Business
Table 67. NTP Radioisotopes Latest Developments
Table 68. JSC Isotope Details, Company Type, Nuclide Area Served and Its Competitors
Table 69. JSC Isotope Nuclide Product Offered
Table 70. JSC Isotope Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. JSC Isotope Main Business
Table 72. JSC Isotope Latest Developments
Table 73. ANM (ANSTO Nuclear Medicine) Details, Company Type, Nuclide Area Served and Its Competitors
Table 74. ANM (ANSTO Nuclear Medicine) Nuclide Product Offered
Table 75. ANM (ANSTO Nuclear Medicine) Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. ANM (ANSTO Nuclear Medicine) Main Business
Table 77. ANM (ANSTO Nuclear Medicine) Latest Developments
Table 78. Nusano Details, Company Type, Nuclide Area Served and Its Competitors
Table 79. Nusano Nuclide Product Offered
Table 80. Nusano Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Nusano Main Business
Table 82. Nusano Latest Developments
Table 83. International Isotopes Details, Company Type, Nuclide Area Served and Its Competitors
Table 84. International Isotopes Nuclide Product Offered
Table 85. International Isotopes Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. International Isotopes Main Business
Table 87. International Isotopes Latest Developments
Table 88. NorthStar Medical Radioisotopes Details, Company Type, Nuclide Area Served and Its Competitors
Table 89. NorthStar Medical Radioisotopes Nuclide Product Offered
Table 90. NorthStar Medical Radioisotopes Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. NorthStar Medical Radioisotopes Main Business
Table 92. NorthStar Medical Radioisotopes Latest Developments
Table 93. China Isotope & Radiation Details, Company Type, Nuclide Area Served and Its Competitors
Table 94. China Isotope & Radiation Nuclide Product Offered
Table 95. China Isotope & Radiation Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. China Isotope & Radiation Main Business
Table 97. China Isotope & Radiation Latest Developments
Table 98. NRG Details, Company Type, Nuclide Area Served and Its Competitors
Table 99. NRG Nuclide Product Offered
Table 100. NRG Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. NRG Main Business
Table 102. NRG Latest Developments
Table 103. Polatom Details, Company Type, Nuclide Area Served and Its Competitors
Table 104. Polatom Nuclide Product Offered
Table 105. Polatom Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Polatom Main Business
Table 107. Polatom Latest Developments
Table 108. ASP Isotopes Details, Company Type, Nuclide Area Served and Its Competitors
Table 109. ASP Isotopes Nuclide Product Offered
Table 110. ASP Isotopes Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. ASP Isotopes Main Business
Table 112. ASP Isotopes Latest Developments
Table 113. Rosatom Details, Company Type, Nuclide Area Served and Its Competitors
Table 114. Rosatom Nuclide Product Offered
Table 115. Rosatom Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Rosatom Main Business
Table 117. Rosatom Latest Developments
Table 118. Eckert & Ziegler Details, Company Type, Nuclide Area Served and Its Competitors
Table 119. Eckert & Ziegler Nuclide Product Offered
Table 120. Eckert & Ziegler Nuclide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Eckert & Ziegler Main Business
Table 122. Eckert & Ziegler Latest Developments
LIST OF FIGURES
Figure 1. Nuclide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nuclide Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Nuclide Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Nuclide Sales Market Share by Country/Region (2025)
Figure 8. Nuclide Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Nuclide Market Size Market Share by Type in 2025
Figure 10. Nuclide in Industry
Figure 11. Global Nuclide Market: Industry (2021-2026) & ($ millions)
Figure 12. Nuclide in Medical
Figure 13. Global Nuclide Market: Medical (2021-2026) & ($ millions)
Figure 14. Nuclide in Other
Figure 15. Global Nuclide Market: Other (2021-2026) & ($ millions)
Figure 16. Global Nuclide Market Size Market Share by Application in 2025
Figure 17. Global Nuclide Revenue Market Share by Player in 2025
Figure 18. Global Nuclide Market Size Market Share by Region (2021-2026)
Figure 19. Americas Nuclide Market Size 2021-2026 ($ millions)
Figure 20. APAC Nuclide Market Size 2021-2026 ($ millions)
Figure 21. Europe Nuclide Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Nuclide Market Size 2021-2026 ($ millions)
Figure 23. Americas Nuclide Value Market Share by Country in 2025
Figure 24. United States Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Nuclide Market Size Market Share by Region in 2025
Figure 29. APAC Nuclide Market Size Market Share by Type (2021-2026)
Figure 30. APAC Nuclide Market Size Market Share by Application (2021-2026)
Figure 31. China Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 35. India Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Nuclide Market Size Market Share by Country in 2025
Figure 38. Europe Nuclide Market Size Market Share by Type (2021-2026)
Figure 39. Europe Nuclide Market Size Market Share by Application (2021-2026)
Figure 40. Germany Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 41. France Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Nuclide Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Nuclide Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Nuclide Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Nuclide Market Size 2027-2032 ($ millions)
Figure 54. APAC Nuclide Market Size 2027-2032 ($ millions)
Figure 55. Europe Nuclide Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Nuclide Market Size 2027-2032 ($ millions)
Figure 57. United States Nuclide Market Size 2027-2032 ($ millions)
Figure 58. Canada Nuclide Market Size 2027-2032 ($ millions)
Figure 59. Mexico Nuclide Market Size 2027-2032 ($ millions)
Figure 60. Brazil Nuclide Market Size 2027-2032 ($ millions)
Figure 61. China Nuclide Market Size 2027-2032 ($ millions)
Figure 62. Japan Nuclide Market Size 2027-2032 ($ millions)
Figure 63. Korea Nuclide Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Nuclide Market Size 2027-2032 ($ millions)
Figure 65. India Nuclide Market Size 2027-2032 ($ millions)
Figure 66. Australia Nuclide Market Size 2027-2032 ($ millions)
Figure 67. Germany Nuclide Market Size 2027-2032 ($ millions)
Figure 68. France Nuclide Market Size 2027-2032 ($ millions)
Figure 69. UK Nuclide Market Size 2027-2032 ($ millions)
Figure 70. Italy Nuclide Market Size 2027-2032 ($ millions)
Figure 71. Russia Nuclide Market Size 2027-2032 ($ millions)
Figure 72. Egypt Nuclide Market Size 2027-2032 ($ millions)
Figure 73. South Africa Nuclide Market Size 2027-2032 ($ millions)
Figure 74. Israel Nuclide Market Size 2027-2032 ($ millions)
Figure 75. Turkey Nuclide Market Size 2027-2032 ($ millions)
Figure 76. Global Nuclide Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Nuclide Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Nuclide Market Size 2027-2032 ($ millions)
Figure 1. Nuclide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nuclide Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Nuclide Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Nuclide Sales Market Share by Country/Region (2025)
Figure 8. Nuclide Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Nuclide Market Size Market Share by Type in 2025
Figure 10. Nuclide in Industry
Figure 11. Global Nuclide Market: Industry (2021-2026) & ($ millions)
Figure 12. Nuclide in Medical
Figure 13. Global Nuclide Market: Medical (2021-2026) & ($ millions)
Figure 14. Nuclide in Other
Figure 15. Global Nuclide Market: Other (2021-2026) & ($ millions)
Figure 16. Global Nuclide Market Size Market Share by Application in 2025
Figure 17. Global Nuclide Revenue Market Share by Player in 2025
Figure 18. Global Nuclide Market Size Market Share by Region (2021-2026)
Figure 19. Americas Nuclide Market Size 2021-2026 ($ millions)
Figure 20. APAC Nuclide Market Size 2021-2026 ($ millions)
Figure 21. Europe Nuclide Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Nuclide Market Size 2021-2026 ($ millions)
Figure 23. Americas Nuclide Value Market Share by Country in 2025
Figure 24. United States Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Nuclide Market Size Market Share by Region in 2025
Figure 29. APAC Nuclide Market Size Market Share by Type (2021-2026)
Figure 30. APAC Nuclide Market Size Market Share by Application (2021-2026)
Figure 31. China Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 35. India Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Nuclide Market Size Market Share by Country in 2025
Figure 38. Europe Nuclide Market Size Market Share by Type (2021-2026)
Figure 39. Europe Nuclide Market Size Market Share by Application (2021-2026)
Figure 40. Germany Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 41. France Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Nuclide Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Nuclide Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Nuclide Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Nuclide Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Nuclide Market Size 2027-2032 ($ millions)
Figure 54. APAC Nuclide Market Size 2027-2032 ($ millions)
Figure 55. Europe Nuclide Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Nuclide Market Size 2027-2032 ($ millions)
Figure 57. United States Nuclide Market Size 2027-2032 ($ millions)
Figure 58. Canada Nuclide Market Size 2027-2032 ($ millions)
Figure 59. Mexico Nuclide Market Size 2027-2032 ($ millions)
Figure 60. Brazil Nuclide Market Size 2027-2032 ($ millions)
Figure 61. China Nuclide Market Size 2027-2032 ($ millions)
Figure 62. Japan Nuclide Market Size 2027-2032 ($ millions)
Figure 63. Korea Nuclide Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Nuclide Market Size 2027-2032 ($ millions)
Figure 65. India Nuclide Market Size 2027-2032 ($ millions)
Figure 66. Australia Nuclide Market Size 2027-2032 ($ millions)
Figure 67. Germany Nuclide Market Size 2027-2032 ($ millions)
Figure 68. France Nuclide Market Size 2027-2032 ($ millions)
Figure 69. UK Nuclide Market Size 2027-2032 ($ millions)
Figure 70. Italy Nuclide Market Size 2027-2032 ($ millions)
Figure 71. Russia Nuclide Market Size 2027-2032 ($ millions)
Figure 72. Egypt Nuclide Market Size 2027-2032 ($ millions)
Figure 73. South Africa Nuclide Market Size 2027-2032 ($ millions)
Figure 74. Israel Nuclide Market Size 2027-2032 ($ millions)
Figure 75. Turkey Nuclide Market Size 2027-2032 ($ millions)
Figure 76. Global Nuclide Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Nuclide Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Nuclide Market Size 2027-2032 ($ millions)
